Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation
about
Aurora B expression correlates with aggressive behaviour in glioblastoma multiformeAurora Kinase Inhibitors: Current Status and OutlookAurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A ReviewOptimization of Imidazo[4,5- b ]pyridine-Based Kinase Inhibitors: Identification of a Dual FLT3/Aurora Kinase Inhibitor as an Orally Bioavailable Preclinical Development Candidate for the Treatment of Acute Myeloid LeukemiaAurora isoform selectivity: design and synthesis of imidazo[4,5-b]pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cells.A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity.Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicityAurora kinases in head and neck cancerPhosphatase inhibitor-2 balances protein phosphatase 1 and aurora B kinase for chromosome segregation and cytokinesis in human retinal epithelial cells.Protein tyrosine phosphatase Shp2 (Ptpn11) plays an important role in maintenance of chromosome stabilitySignificance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.Update: the status of clinical trials with kinase inhibitors in thyroid cancerAnaplastic thyroid cancer: molecular pathogenesis and emerging therapies.Spindle proteins are differentially expressed in the various histological subtypes of testicular germ cell tumors.A new aurora in anaplastic thyroid cancer therapy.Inhibition of Aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway in vitroThe ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B.Understanding cytokinesis failure.Deregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumorsKnockdown of Aurora-B inhibits the growth of non-small cell lung cancer A549 cells.Transcriptional activation of human CDCA8 gene regulated by transcription factor NF-Y in embryonic stem cells and cancer cellsReversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells.Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development.Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins.Aurora A and B kinases as targets for cancer: will they be selective for tumors?Targeting Aurora kinases in ovarian cancer.Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B.Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines.Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability.FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinomaA phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors.Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancerAurora kinase inhibitors: progress towards the clinicMitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis.Mitosis as an anti-cancer drug target.Genetics and epigenetics of sporadic thyroid cancer.Targeting mitotic pathways for endocrine-related cancer therapeutics.Histone modifying enzymes: novel disease biomarkers and assay development.
P2860
Q24676207-4C30FD2C-FEB4-471F-A031-AC32EF62E6E4Q26770583-883EB060-9901-437C-9586-A4886CAD2B8DQ26783412-D4680AC3-59D0-4A6F-8FAD-44B24B5B360FQ27674324-52F76A6E-E27E-44AC-8F6E-B947FF8EFCFEQ27680538-4F99F871-7374-4FD2-A15C-9B76ED4653C1Q28115595-D364BA34-182C-4986-9353-389A54A1D358Q28571256-32D35CDF-7C5F-4AA7-A2C5-CF268BA994DFQ28654389-05626407-E721-4449-B793-A3E9CF3BFFC0Q30440583-1F9107DB-04EB-4364-B85C-5C59F1DDF780Q30525672-03B8D170-F634-4A87-9A75-9D580EE85C71Q30988387-DA22A237-A86F-4AC3-9C81-1B1888AA34D7Q33570056-DB920E16-FB0B-4D08-9D80-42435DFDF750Q33691759-B3EFE908-500A-462A-B5BD-1DEFB60500BCQ33795520-3B92FE79-9027-4240-817F-599F7D3D3574Q33930368-1878F31E-AC8C-43B4-95CC-82548F9B686CQ33962378-ACA413A7-1FC4-4A5A-9449-326E59BA75EFQ34166850-42ABBE97-B9FA-4E29-B083-013B42870F55Q34717820-A9851A13-D0B5-4A65-9E71-CCEB5DF099F8Q35217023-767AFA59-DCB4-43E2-B451-D6703CAE27CDQ35289072-DDADB6B5-D44F-4F22-9C06-3D408145618EQ35944474-3C3580FB-D87F-4AEE-A9BD-DA95CA2F60F3Q36049891-10F4E816-7C64-4988-B752-8F11AE46E10CQ36069311-1C53148F-F1D3-4AFC-A353-81B7598E09BBQ36070046-0CCB0B3B-91D4-4FE1-AED6-632DC8B9F2A9Q36332561-C6D6D856-6DE9-4E89-80F0-B646A71E2089Q36352091-46E66473-BBAD-4A70-BD49-248B57AA004BQ36379376-AE463F17-1EE8-4CC8-882E-B4EAD04B8441Q36435773-DF210550-A3EC-4E5E-A5C7-84AE9A302EB0Q36610272-5C9ECAF0-A2BC-4274-BB66-628C05D4CF42Q36615322-98E89035-E766-4291-80EB-7EE96F8E61B1Q36799818-1F335105-884E-44A9-8FC9-1488C005AFA9Q37366202-18C4A5CB-3418-4613-B444-9803DA759745Q37526802-A7B35D34-FE4F-41FB-99F2-8415107DD064Q37986455-E64C3914-F3B2-44B3-9856-D42AEC69E4D3Q38030445-7ED4FF68-788A-4F00-A474-BAD1E4DA1BF0Q38101000-B9DD6ED9-6595-4D37-BDA4-36143FEBDB1CQ38115166-62EBDF81-B435-44F7-9CF6-2A96145C6B81Q38128097-66179395-00B2-4995-B7BD-E18692D9350DQ38671036-8C781349-E054-4CD9-80C4-8268DD9E6287Q38691865-C6E741A1-0A72-4105-B199-24134ECB159F
P2860
Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Aurora B overexpression associ ...... d carcinoma cell proliferation
@ast
Aurora B overexpression associ ...... d carcinoma cell proliferation
@en
Aurora B overexpression associ ...... d carcinoma cell proliferation
@nl
type
label
Aurora B overexpression associ ...... d carcinoma cell proliferation
@ast
Aurora B overexpression associ ...... d carcinoma cell proliferation
@en
Aurora B overexpression associ ...... d carcinoma cell proliferation
@nl
prefLabel
Aurora B overexpression associ ...... d carcinoma cell proliferation
@ast
Aurora B overexpression associ ...... d carcinoma cell proliferation
@en
Aurora B overexpression associ ...... d carcinoma cell proliferation
@nl
P2093
P50
P3181
P356
P1476
Aurora B overexpression associ ...... d carcinoma cell proliferation
@en
P2093
Daniela Spalletti-Cernia
Giancarlo Troncone
Giuseppe Portella
Lucio Palombini
Paolo Laccetti
Pier Lorenzo Pallante
Rosanna Sorrentino
Silvana Libertini
Vassilios Bavetsias
P304
P3181
P356
10.1210/JC.2004-1518
P407
P577
2004-11-23T00:00:00Z